A quick note first: I searched the library and don't have a "Kumar S Textbook of Microbiology" specifically (the closest microbiology titles available are Jawetz, Melnick & Adelberg's, Sherris & Ryan's, and Medical Microbiology 9e). CLABSI (Central Line-Associated Bloodstream Infection) and its prevention bundle is actually infection-control/critical-care content rather than core microbiology, so I pulled corroborating material from Current Surgical Therapy, 14e and other clinical texts in the library, which cover this in depth.

Your handwritten outline is for an assignment titled "CLABSI and Their Bundles". Here is the topic map from your plan:

CRBSI (catheter-related bloodstream infection) and CLABSI are related but distinct terms. CRBSI is a clinical diagnosis confirmed by specific lab testing (catheter tip culture, quantitative blood cultures, or differential time-to-positivity) after ruling out other infection sources - it applies to both peripheral and central catheters. CLABSI is a standardized surveillance definition used by the CDC/NHSN: a laboratory-confirmed bloodstream infection in a patient who has had a central venous catheter (CVC) in place for at least 48 hours, with no infection traceable to another site. Because it doesn't require proof the catheter was the actual source, CLABSI surveillance rates can overestimate true CRBSI incidence - Current Surgical Therapy 14e, p. (block17).

Since 2008, CMS classified CLABSI as a preventable hospital-acquired infection and stopped reimbursing for it, which drove major national reductions (46% decrease 2008-2013) through standardized care bundles for CVC insertion and maintenance. Notably, the COVID-19 pandemic reversed this trend, with a 28% rise in the standardized infection ratio (SIR) from 2019 to 2020 due to high-acuity ICU strain - Current Surgical Therapy 14e.

Risk generally centers on catheter dwell time, insertion site (femoral > internal jugular > subclavian risk), breaks in aseptic technique, immunosuppression, and multiple lumens/frequent line access. The prevention bundle (the core of your section 7) typically includes: hand hygiene, maximal sterile barrier precautions during insertion, chlorhexidine skin antisepsis, optimal catheter site selection (avoiding the femoral vein when possible), and daily review of line necessity with prompt removal when no longer needed - these bundle elements are drawn from CDC/IHI evidence-based guidelines referenced across several library texts.

Given how many distinct sections this assignment covers, I'd rather go deep on one at a time so you get full, well-cited content instead of a thin pass over everything.